| ClearPoint beta-Amyloid (1-38), 13C-Phe & Ile - 0.05 mg | | | CEF25, Influenza Virus NP (44-52) - 1 mg | | | Caspase 9 Substrate 1, chromogenic - 5 mg | | | C5a Receptor Agonist, mouse, human - 1 mg | | | CEF8, Influenza Virus NP (383-391) - 1 mg | | | CL-APC (Cross Linked-Allophycocyanin) - 1 mg | | | CDK7/9 tide [YSPTSPSYSPTSPSYSPTSPSKKKK] - 1 mg | | | CDK5 Substrate [PKTPKKAKKL] - 1 mg | | | CAP-18, rabbit - 0.5 mg | | | CEF11, Epstein-Barr Virus BMLF1 (280-288) - 1 mg | | | Caspase 1 (ICE) Inhibitor II - 1 mg | 178603-78-6 | C24H33ClN4O8 | С3А (70-77) | 63555-63-5 | C35H61N13O10 | КАЛЬПАИН-ИНГИБИТОР ПЕПТИД | 128578-18-7 | C140H227N35O44S | КАЛЬЦЕИН СИНИЙ, AM | 168482-84-6 | C21H23NO11 | АЛЬФА-CGRP (Крыса) | 83651-90-5 | C162H262N50O52S2 | Calcitonin Gene Related Peptide, CGRP (beta), human - 0.5 mg | 101462-82-2 | C162-H267-N51O48S3 | CMVpp65-4 (SVLGPISGHVLKAVF) - 1 mg | | | Caloxin 1B1 - 1 mg | | | Cls Substrate, C2 (5-FAM/ QXL® 520) - 0.5 mg | | | CFP10 (71–85) - 1 mg | | | ЧАРИБДОТОКСИН | 95751-30-7 | C176H277N57O55S7 | Конго красный | 573-58-0 | C32H22N6Na2O6S2 | Caspase 3 (Apopain) Substrate 1m, fluorogenic - 5 mg | 169332-61-0 | C30H37N5O13 | Bradykinin Antagonist, HOE I40 - 1 mg | 130308-48-4 | C59H89N19O13S | БНП-45 (Крыса) | 123337-89-3 | C213H349N71O65S3 | БУФОРИН II | 172998-24-2 | C106H184N40O26 | Corticotropin Releasing Factor, CRF, human, rat - 1 mg | 86784-80-7 | C208H344N60O63S2 | Calcitonin, salmon - 5 mg | 47931-85-1 | C145H240N44O48S2 | Брадикинин | 58-82-2 | C50H73N15O11 | CEF2, Influenza Virus PA (46-54) - 1 mg | | | Collagen (Type IV), FAM conjugated - 1 mg | | | CEF Control Peptide Pool - 8 mg | | | Caspase 1 (ICE) Inhibitor II, biotinylated - 1 mg | | | CEF10, Epstein-Barr Virus LMP2 (426-434) - 1 mg | | | B-type Natriuretic Peptide, BNP-45, mouse - 0.5 mg | 1816939-52-2 | | Calcitonin Gene Related Peptide, CGRP (alpha), human | 90954-53-3 | C163H267N51O49S2 | Caerulein | 17650-98-5 | C58H73N13O21S2 | Броксуридин | 59-14-3 | C9H11BrN2O5 | Caloxin 2A1 - 1 mg | 350670-85-8 | C64H91N19O22 | Collagen (Type I), FITC conjugated Water soluble - 1 mg | | | CEF Control Peptide Pool - 16 mg | | | Caspase 8 Substrate 1f, fluorogenic - 5 mg | | | BSA-HiLyte Fluor 647 Conjugate -5 mg | | | CEF Control Peptide Pool - 1 mg | | | ClearPoint beta-Amyloid (1-42), 13C, 15N-labeled at Arg & Lys - 50 μg | | | BSA-Biotin Conjugate -10 mg | | | ХЛОРОТОКСИН | 163515-35-3 | C158H249N53O47S11 | (Z-ASP-GLU-VAL-ASP)2-РОДАМИН 110 | 223538-61-2 | C72H78N10O27 | C5a Receptor Antagonist, linear, human, rat - 1 mg | | | Caloxin 3A1 - 1 mg | | | CK1 Peptide Substrate [pS7] [KRRRAL-pS-VASLPGL] - 1 mg | | | Cardiac Ryanodine Receptor RYR2 (2460-2495) - 1 mg | | | Caspase 3 (Apopain) Substrate 1f-z, fluorogenic - 5 mg | | | Мастопаран | 72093-21-1 | C70H131N19O15 | Cecropin A Peptide | 80451-04-3 | C184H313N53O46 | Colivelin - 1 mg | 867021-83-8 | C119H206N32O35 | CRF (овечий) трифторацетат | 79804-71-0 | C205H339N59O63S | ЦКС 17 | 99273-04-8 | C87H148N26O24 | Cathepsin S Substrate - 1 mg | 1135686-31-5 | C41H66N12O9 | Cls Substrate, C2 (Abz/Dnp) - 1 mg | | | Calcitonin Gene Related Peptide, CGRP (alpha), human, Biotin-LC-labeled - 1 mg | | | ClearPoint beta-Amyloid (1-40), 13C, 15N-labeled at Arg & Lys - 50 μg | | | CEF30, Epstein-Barr Virus BRLF1 (134-142) - 1 mg | | | Conantokin G - 0.5 mg | 133628-78-1 | C88H137N25O45 | Cell Adhesive Peptide [RGDC] - 1 mg | 109292-46-8 | C15H27N7O7S | Х-АСН-ЛЕУ-ВАЛ-ПРО-МЕТ-ВАЛ-АЛА-ТР-ВАЛ-ОН | 153045-21-7 | C42H74N10O12S | Cathepsin K substrate - 0.1 mg | | | B-PE (B-Phycoerythrin) - 1 mg | | | Chemerin (149-157) - 1 mg | | | BSA-HiLyte Fluor 555 Conjugate -5 mg | | | Caspase 3 (Apopain) Substrate 1, chromogenic - 5 mg | 189950-66-1 | C26H34N6O13 | BSB [(trans,trans)-1-Bromo-2.5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene] - 5 mg | 56776-28-4 | C28H23NaO6S2 | SUC-Leu-Leu-Val-Tyr-АМС | 94367-21-2 | C40H53N5O10 | КАЛЬЦЕЙН-АМ | 148504-34-1 | C46H46N2O23 | Caspase 9 Substrate 1f, fluorogenic - 5 mg | 210345-03-2 | C33H38F3N7O11 | Caspase 8 Substrate 1, chromogenic - 5 mg | 219138-21-3 | C27H38N6O12 | CEF19, Epstein-Barr Virus latent NA-3A (458-466) - 1 mg | | | Calpain Substrate, Fluorogenic, (Z-AA)2Rh110 - 5 mg | | | C34, gp41 HIV Fragment - 1 mg | | | Casein Kinase 2 (CK2) Substrate alpha-subunit [RRRDDDSDDD] - 1 mg | | | CEF26, Influenza Virus NP (265-274) - 1 mg | | | Caspase 3 (Apopain) Substrate 1f, fluorogenic - 5 mg | 201608-14-2 | C30H34F3N5O13 | CEF1, Influenza Matrix Protein M1 (58-66) - 1 mg | 141368-69-6 | C49H75N9O11 | Calcitonin Gene Related Peptide, CGRP (alpha) (8-37), human - 1 mg | 119911-68-1 | C139H230N44O38 | Caspase 1 (ICE) Substrate 3f, fluorogenic - 5 mg | 210344-99-3 | C38H37F3N8O11 | Синкалид | 25126-32-3 | C49H62N10O16S3 | BSA-HiLyte Fluor 488 Conjugate -5 mg | | | BSA-HiLyte Fluor 750 Conjugate -5 mg | | | Collagen alpha1(I) C-Telopeptide (614-639), human - 1 mg | | | B-type Natriuretic Peptide, BNP-32, human | 114471-18-0 | C143H244N50O42S4 | CDK1 Substrate [HATPPKKKRK] - 5 mg | | | ClearPoint BSA (347-359), Isotopic labeled, Mass Spec Standard - 0.1 mg | | | Calcitonin, human | 21215-62-3 | C151H226N40O45S3 | Cecropin B - 0.5 mg | 80451-05-4 | C176H302N52O41S | Caspase 1 (ICE) Substrate 2, chromogenic - 5 mg | 149231-66-3 | C29H36N6O10 | Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) - 1 mg | 1678417-57-6 | | Cholecystokinin (26-33), CCK8, Non-Sulfated CCK-8 - 1 mg | 25679-24-7 | C49H62N10O13S2 | Cathepsin D and E FRET Substrate - 1 mg | | | c-Myc peptide epitope | | C43H69N11O14 | Collagen (Type I), FITC conjugated Water Insoluble - 5 mg | | |